SeaStar Medical Holding Corp ICU
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-01-26 |
| Shares Out. | 4,000,000 |
| Website | seastarmedical.com ↗ |
| Phone | 18444278100 |
| Employees | 17 |
| Revenue | $495,000 |
| Gross Profit | $449,000 |
| Net Income | -$3.5M |
| Total Assets | $11.3M |
| Total Liabilities | $3.9M |
| Equity | $7.3M |
About SeaStar Medical Holding Corp
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
SeaStar Medical Holding Corp is a publicly traded company under the ticker symbol ICU on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
5 analysts (2026-07-01)